{
    "clinical_study": {
        "@rank": "101010", 
        "acronym": "PPWL", 
        "arm_group": [
            {
                "arm_group_label": "DMPA group", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects randomized to receive DepoProvera(DMPA) immediately post-partum."
            }, 
            {
                "arm_group_label": "Implanon group", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects randomized to receive Implanon immediately post-partum."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "Subjects selecting their own method of contraception or no contraception."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective mixed methods study to assess weight changes in women randomized to\n      receive Implanon \u00ae or Depo Provera\u00ae (DMPA) immediately postpartum compared to women who\n      choose non-hormonal contraception or no contraception immediately postpartum. After\n      enrollment, subjects return for a visit at 3, 6 and 12 months postpartum to be asked a\n      series of questions, take a pregnancy test, and be weighed. Total length of participation\n      for each subject is 1 year or until pregnancy."
        }, 
        "brief_title": "The Impact of Contraception on Postpartum Weight Loss", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Weight", 
        "condition_browse": {
            "mesh_term": "Weight Loss"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  English speaking\n\n          -  Aged 18-45 at enrollment (inclusive)\n\n          -  Immediately postpartum of a live singleton infant, 37 weeks gestation, at HUP\n\n          -  Desiring to delay another pregnancy for 6 months\n\n          -  Willing and able to follow the study protocol\n\n        Exclusion Criteria:\n\n          -  Breastfeeding during study participation\n\n          -  Plans for relocation outside of Philadelphia in the next six months\n\n          -  Plans for use of weight loss medication or diet pills in the next six months\n\n          -  Women who wish to start Implanon \u00ae or DMPA prior to discharge but who do not want to\n             be randomized. 5. Issues or concerns in the judgment of the investigator that may\n             compromise the safety of the subject or confound the reliability of compliance and\n             information acquired in this study"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02144259", 
            "org_study_id": "813000"
        }, 
        "intervention": [
            {
                "arm_group_label": "DMPA group", 
                "description": "DMPA is an intramuscular injection of 150mg of depot medroxyprogesterone acetate.", 
                "intervention_name": "DMPA immediately postpartum", 
                "intervention_type": "Drug", 
                "other_name": "DepoProvera, depot medroxyprogesterone acetate (DMPA)"
            }, 
            {
                "arm_group_label": "Implanon group", 
                "description": "Implanon \u00ae is a subdermal implant that contains 68mg of etonogesterel.", 
                "intervention_name": "Implanon immediately postpartum", 
                "intervention_type": "Drug", 
                "other_name": "etonogestrel implant"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Medroxyprogesterone", 
                "Medroxyprogesterone Acetate", 
                "3-keto-desogestrel"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "June 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19104"
                }, 
                "name": "University of Pennsylvania"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "The Impact of Contraception on Postpartum Weight Loss: a Prospective Study", 
        "other_outcome": {
            "description": "Satisfaction will be measured by the occurrence of unscheduled clinical visits to other facilities and responses to a series of questions to assess contraceptive continuation rates, contraceptive satisfaction, and bleeding patterns.", 
            "measure": "Contraceptive satisfaction", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "overall_official": {
            "affiliation": "University of Pennsylvania", 
            "last_name": "Courtney A Schreiber, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Weight will be measured at 3, 6 and 12 months postpartum. Percent weight change will be compared amongst the groups", 
            "measure": "Weight change", 
            "safety_issue": "No", 
            "time_frame": "6 months postpartum"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02144259"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pennsylvania", 
            "investigator_full_name": "Courtney Schreiber", 
            "investigator_title": "Director, Fellowship in Family Planning", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The secondary outcome variables is pregnancy rate. Pregnancy testing will occur at 3, 6 and 12 months postpartum.", 
            "measure": "Pregnancy rate", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "source": "University of Pennsylvania", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Pennsylvania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2011", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}